Critically, FLLL31 exhibits enhanced bioavailability and metabolic stability relative to parental curcumin, enabling selective tumor cytotoxicity via coordinated upregulation of FOXO4, activation of BCL6, and suppression of Bcl‐xL‐mediated mitochondrial apoptotic inhibition. This evidence concerns the gene BCL2L1 and neoplasm.